Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
348.4 USD | -0.74% | +2.02% | +16.34% |
May. 10 | Bernstein Adjusts Price Target on Cigna to $411 From $389 | MT |
May. 06 | UBS Adjusts Cigna Price Target to $410 From $400, Maintains Buy Rating | MT |
Financials (USD)
Sales 2024 * | 236B | Sales 2025 * | 247B | Capitalization | 98.97B |
---|---|---|---|---|---|
Net income 2024 * | 5.3B | Net income 2025 * | 7.16B | EV / Sales 2024 * | 0.52 x |
Net Debt 2024 * | 22.81B | Net Debt 2025 * | 19.26B | EV / Sales 2025 * | 0.48 x |
P/E ratio 2024 * |
18.4
x | P/E ratio 2025 * |
13.3
x | Employees | 71,413 |
Yield 2024 * |
1.6% | Yield 2025 * |
1.72% | Free-Float | 69.59% |
Latest transcript on Cigna
1 day | -0.74% | ||
1 week | +2.02% | ||
Current month | -2.42% | ||
1 month | -2.64% | ||
3 months | +4.02% | ||
6 months | +18.82% | ||
Current year | +16.34% |
Managers | Title | Age | Since |
---|---|---|---|
David Cordani
CEO | Chief Executive Officer | 58 | 90-12-31 |
Brian Evanko
DFI | Director of Finance/CFO | 48 | - |
Paul Sanford
COO | Chief Operating Officer | - | 21-09-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 17-12-31 | |
David Cordani
CEO | Chief Executive Officer | 58 | 90-12-31 |
Donna Zarcone
BRD | Director/Board Member | 66 | 04-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.33% | 0 M€ | +4.88% | ||
2.28% | 0 M€ | +7.69% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 348.4 | -0.74% | 1,675,308 |
24-05-09 | 351 | +1.04% | 1,388,775 |
24-05-08 | 347.4 | +0.19% | 1,355,254 |
24-05-07 | 346.7 | +1.25% | 1,567,974 |
24-05-06 | 342.4 | +0.27% | 1,339,270 |
Delayed Quote Nyse, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.34% | 98.97B | |
-2.59% | 472B | |
+14.34% | 125B | |
+4.82% | 41.51B | |
-1.86% | 20.78B | |
-25.95% | 2.65B | |
-20.67% | 1.31B | |
-13.87% | 407M |
- Stock Market
- Equities
- CI Stock